Given the protective role of AMPKα2 and deleterious role of AMPKα1 in the kidney, we hypothesize that selective activation of AMPKα2-containing isoforms may have the potential to slow ADPKD progression. This evidence concerns the gene PRKAA2 and autosomal dominant polycystic kidney disease.